VAXXINITY INC
(NASDAQ: VAXX)
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
0.467
+0.049
(+11.72%)
Range
- - -
(-%)
Open
-
Previous Close
0.418
Bid Price
1.890
Bid Volume
11
Ask Price
1.980
Ask Volume
8
Volume
435,667
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis